Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5707579 | 1.00 | NPC1 (0.31) | NPC1RAB9AALDH1A1KMT2A | |
| SCHEMBL5707655 | 0.86 | NPC1 (0.32) | NPC1RAB9A | |
| SCHEMBL5707590 | 0.78 | NPC1 (0.33) | NPC1RAB9AALDH1A1KMT2A | |
| SCHEMBL8588060 | 0.77 | SLC6A2 (0.31) | — | |
| SCHEMBL5707591 | 0.77 | NPC1 (0.32) | NPC1RAB9A | |
| SCHEMBL5707623 | 0.76 | NPC1 (0.31) | NPC1RAB9AALDH1A1 | |
| SCHEMBL5707551 | 0.75 | NPC1 (0.32) | NPC1RAB9AALDH1A1 | |
| SCHEMBL4982728 | 0.74 | P2RX7 (0.32) | NPC1RAB9AALDH1A1KMT2A | |
| SCHEMBL5707571 | 0.74 | P2RX7 (0.32) | NPC1RAB9AALDH1A1KMT2A | |
| SCHEMBL5707632 | 0.74 | P2RX7 (0.32) | NPC1RAB9AALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060229275-A1 | Production method of 2-deoxy-L-ribofuranosyl chloride compound | AJINOMOTO CO. INC (JP) | 2006-10-12 | — | — | US | disclosed |
| EP-1705181-A2 | Production method of 2-deoxy-L-ribofuranosyl chloride compound | AJINOMOTO CO., INC. (JP) | 2006-09-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060229275-A1 | Production method of 2-deoxy-L-ribofuranosyl chloride compound | DCTD, DERA, HDHD5 | NPC1 2614/4885RAB9A 2001/4885ALDH1A1 637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.